133 related articles for article (PubMed ID: 18207609)
1. Hypotensive activity of novokinin, a potent analogue of ovokinin(2-7), is mediated by angiotensin AT(2) receptor and prostaglandin IP receptor.
Yamada Y; Yamauchi D; Usui H; Zhao H; Yokoo M; Ohinata K; Iwai M; Horiuchi M; Yoshikawa M
Peptides; 2008 Mar; 29(3):412-8. PubMed ID: 18207609
[TBL] [Abstract][Full Text] [Related]
2. Orally administered novokinin, an angiotensin AT2 receptor agonist, suppresses food intake via prostaglandin E2-dependent mechanism in mice.
Ohinata K; Fujiwata Y; Shingo F; Masaru I; Masatsugu H; Yoshikawa M
Peptides; 2009 Jun; 30(6):1105-8. PubMed ID: 19463743
[TBL] [Abstract][Full Text] [Related]
3. A potent hypotensive peptide, novokinin, induces relaxation by AT2- and IP-receptor-dependent mechanism in the mesenteric artery from SHRs.
Yamada Y; Yamauchi D; Yokoo M; Ohinata K; Usui H; Yoshikawa M
Biosci Biotechnol Biochem; 2008 Jan; 72(1):257-9. PubMed ID: 18175894
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive activity of transgenic rice seed containing an 18-repeat novokinin peptide localized in the nucleolus of endosperm cells.
Wakasa Y; Zhao H; Hirose S; Yamauchi D; Yamada Y; Yang L; Ohinata K; Yoshikawa M; Takaiwa F
Plant Biotechnol J; 2011 Sep; 9(7):729-35. PubMed ID: 21078052
[TBL] [Abstract][Full Text] [Related]
5. Rapakinin, an anti-hypertensive peptide derived from rapeseed protein, dilates mesenteric artery of spontaneously hypertensive rats via the prostaglandin IP receptor followed by CCK(1) receptor.
Yamada Y; Iwasaki M; Usui H; Ohinata K; Marczak ED; Lipkowski AW; Yoshikawa M
Peptides; 2010 May; 31(5):909-14. PubMed ID: 20188776
[TBL] [Abstract][Full Text] [Related]
6. The pharmacological effects of novokinin; a designed peptide agonist of the angiotensin AT2 receptor.
Yoshikawa M; Ohinata K; Yamada Y
Curr Pharm Des; 2013; 19(17):3009-12. PubMed ID: 23176213
[TBL] [Abstract][Full Text] [Related]
7. Anti-hypertensive activity of genetically modified soybean seeds accumulating novokinin.
Yamada Y; Nishizawa K; Yokoo M; Zhao H; Onishi K; Teraishi M; Utsumi S; Ishimoto M; Yoshikawa M
Peptides; 2008 Mar; 29(3):331-7. PubMed ID: 18226422
[TBL] [Abstract][Full Text] [Related]
8. Met-Arg-Trp derived from Rubisco lowers blood pressure via prostaglandin D(2)-dependent vasorelaxation in spontaneously hypertensive rats.
Zhao H; Usui H; Ohinata K; Yoshikawa M
Peptides; 2008 Mar; 29(3):345-9. PubMed ID: 18180074
[TBL] [Abstract][Full Text] [Related]
9. Design of a highly potent anti-hypertensive peptide based on ovokinin(2-7).
Yamada Y; Matoba N; Usui H; Onishi K; Yoshikawa M
Biosci Biotechnol Biochem; 2002 Jun; 66(6):1213-7. PubMed ID: 12162540
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin AT(2) receptor agonists act as anti-opioids via EP(3) receptor in mice.
Yamada Y; Ohinata K; Lipkowski AW; Yoshikawa M
Peptides; 2009 Apr; 30(4):735-9. PubMed ID: 19084563
[TBL] [Abstract][Full Text] [Related]
11. Designing potent derivatives of ovokinin(2-7), an anti-hypertensive peptide derived from ovalbumin.
Matoba N; Yamada Y; Usui H; Nakagiri R; Yoshikawa M
Biosci Biotechnol Biochem; 2001 Mar; 65(3):736-9. PubMed ID: 11330703
[TBL] [Abstract][Full Text] [Related]
12. Novokinin inhibits gastric acid secretion and protects against alcohol-induced gastric injury in rats.
Zhang Y; Xiu M; Jiang J; He J; Li D; Liang S; Chen Q
Alcohol; 2016 Nov; 56():1-8. PubMed ID: 27814789
[TBL] [Abstract][Full Text] [Related]
13. Rapakinin, Arg-Ile-Tyr, derived from rapeseed napin, shows anti-opioid activity via the prostaglandin IP receptor followed by the cholecystokinin CCK(2) receptor in mice.
Yamada Y; Ohinata K; Lipkowski AW; Yoshikawa M
Peptides; 2011 Feb; 32(2):281-5. PubMed ID: 21129424
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II-mediated vasodilation is reduced in adult spontaneously hypertensive rats despite enhanced expression of AT2 receptors.
Ognibene DT; Oliveira PR; Marins de Carvalho LC; Costa CA; Espinoza LA; Criddle DN; Tano T; Soares de Moura R; Resende AC
Clin Exp Pharmacol Physiol; 2009 Jan; 36(1):12-9. PubMed ID: 18986337
[TBL] [Abstract][Full Text] [Related]
15. A transgenic rice seed accumulating an anti-hypertensive peptide reduces the blood pressure of spontaneously hypertensive rats.
Yang L; Tada Y; Yamamoto MP; Zhao H; Yoshikawa M; Takaiwa F
FEBS Lett; 2006 May; 580(13):3315-20. PubMed ID: 16697378
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Ile-His-Arg-Phe, a novel rice-derived vasorelaxing peptide with hypotensive and anorexigenic activities.
Kontani N; Omae R; Kagebayashi T; Kaneko K; Yamada Y; Mizushige T; Kanamoto R; Ohinata K
Mol Nutr Food Res; 2014 Feb; 58(2):359-64. PubMed ID: 24105961
[TBL] [Abstract][Full Text] [Related]
17. Interaction of ovokinin(2-7) with vascular bradykinin 2 receptors.
Scruggs P; Filipeanu CM; Yang J; Chang JK; Dun NJ
Regul Pept; 2004 Aug; 120(1-3):85-91. PubMed ID: 15177924
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of the antihypertensive activity of orally administered ovokinin, a vasorelaxing peptide derived from ovalbumin, by emulsification in egg phosphatidylcholine.
Fujita H; Sasaki R; Yoshikawa M
Biosci Biotechnol Biochem; 1995 Dec; 59(12):2344-5. PubMed ID: 8611762
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive peptides derived from egg proteins.
Miguel M; Aleixandre A
J Nutr; 2006 Jun; 136(6):1457-60. PubMed ID: 16702303
[TBL] [Abstract][Full Text] [Related]
20. Optimal designing of beta-conglycinin to genetically incorporate RPLKPW, a potent anti-hypertensive peptide.
Onishi K; Matoba N; Yamada Y; Doyama N; Maruyama N; Utsumi S; Yoshikawa M
Peptides; 2004 Jan; 25(1):37-43. PubMed ID: 15003354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
